ABT

How ABT Has Traded Around Recent Earnings

Over the last eight reported quarters, Abbott Laboratories (ABT) carries a 4/8 (100%) beat rate with an average earnings surprise of 0.7%, according to the data. That small average surprise indicates results have landed close to the published estimate rather than blowing it out. The more telling number is the average five-day price move after earnings: -1.17%, classified as a "down" drift. In practical terms, even when ABT meets or exceeds expectations, the stock has historically faced selling pressure in the week that follows.

The last four reports spell out the pattern in detail. On July 16, 2026, ABT reported $1.31 versus a $1.28 estimate, a 2.3% beat, and the stock rose 1.87% the next day and 1.94% over the following five sessions — the exception to the rule. The April 16, 2026 report also beat, with $1.15 against $1.14, but after a 1.4% next-day gain the five-day drift was -3.13%. The two quarters before that were inline: January 22, 2026 ($1.50 vs. $1.50) produced a -1.1% next-day move and -2.32% over five days, while October 15, 2025 ($1.30 vs. $1.30) saw -1.41% the next day and -1.16% over five days. Three of the last four quarterly windows ended in negative five-day drift, which is where the -1.17% average comes from.

Options-Flow Context Heading into the October 21 Report

The next scheduled report is October 21, 2026, before the open, with a consensus EPS estimate of $1.42. At a current price of $107.43, options expiring around that date will embed an expected move that reflects both the 0.7% historical average surprise and the -1.17% post-earnings drift. If the implied move is priced wide relative to those historical averages, the setup can reward sellers of premium who expect the post-report reaction to be smaller than advertised. With the RSI at 69.5 and price roughly $10.61 above the 50-day EMA of $96.82, short-term momentum is extended; that backdrop can amplify a directional response if the $1.42 estimate is missed or if guidance disappoints without a clear beat.

What a Disciplined Trader Watches

A disciplined approach starts with the gap, not the headline. Watch whether ABT opens above or below the $107.43 snapshot level on October 21, then track whether the first 30-minute volume confirms follow-through or reversal. Given the historical -1.17% five-day drift, three of the last four post-earnings moves have faded after the initial reaction — the July 16, 2026 report was the only one of the last four to finish the five-day window higher, at +1.94%. Traders also compare the options-implied move against the actual EPS deviation from $1.42; a large implied move paired with a small 0.7%-style surprise can set up a volatility-crush trade, while a miss or inline result against elevated expectations may accelerate the historical sell-off. Sector positioning in Healthcare/Medical - Devices adds another layer, since device stocks can move on procedure-volume commentary that does not show up in the EPS number.

For a deeper dive into how sell-side and institutional models are positioned around Abbott's October 21 release, readers should look at the full institutional verdict rather than relying on headline inputs alone.